LORISTA H 50mg / 12.50mg tablets medication leaflet

C09DA01 losartan + hydrochlorothiazide • Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

The combination of losartan and hydrochlorothiazide is used to treat high blood pressure and reduce the risk of cardiovascular complications. Losartan is an angiotensin II receptor antagonist that relaxes blood vessels, while hydrochlorothiazide is a diuretic that helps remove excess salt and water from the body.

This combination is effective in lowering blood pressure and reducing the risk of strokes, heart failure, or other cardiovascular conditions. It is typically prescribed for patients who do not respond adequately to monotherapy.

Side effects may include dizziness, headaches, fatigue, electrolyte imbalances, or increased sensitivity to sunlight. Patients should avoid dehydration and inform their doctor about any other medications they are taking.

Pregnant or breastfeeding women should not use this combination, and patients must strictly follow their doctor's recommendations to achieve the best results.

General data about LORISTA H 50mg / 12.50mg

Substance: losartan + hydrochlorothiazide

Date of last drug list: 01-07-2020

Commercial code: W43460004

Concentration: 50mg / 12.50mg

Pharmaceutical form: tablets

Quantity: 28

Product type: generic

Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Marketing authorisation

Manufacturer: KRKA, D.D., NOVO MESTO - SLOVENIA

Holder: KRKA, D.D., NOVO MESTO - SLOVENIA

Number: 8030/2015/04

Shelf life: 5 years

Concentrations available for losartan + hydrochlorothiazide

100mg/12.5mg, 100mg/25mg, 50mg/12.50mg, 50mg/12.5mg

Other substances similar to losartan + hydrochlorothiazide